Gabelli Funds LLC Has $2.53 Million Stock Position in Bel Fuse Inc. (NASDAQ:BELFA)

Share on StockTwits

Gabelli Funds LLC decreased its stake in shares of Bel Fuse Inc. (NASDAQ:BELFA) by 1.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 216,000 shares of the scientific and technical instruments company’s stock after selling 2,397 shares during the quarter. Gabelli Funds LLC owned about 1.76% of Bel Fuse worth $2,530,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Principal Financial Group Inc. bought a new stake in shares of Bel Fuse during the 2nd quarter valued at $811,000. Gamco Investors INC. ET AL increased its stake in shares of Bel Fuse by 4.5% in the second quarter. Gamco Investors INC. ET AL now owns 244,780 shares of the scientific and technical instruments company’s stock valued at $2,453,000 after buying an additional 10,608 shares during the period. Finally, Investors Asset Management of Georgia Inc. GA ADV bought a new stake in shares of Bel Fuse during the 3rd quarter valued at about $123,000. 7.35% of the stock is currently owned by institutional investors and hedge funds.

NASDAQ:BELFA opened at $13.16 on Wednesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 3.17. The stock has a fifty day moving average of $11.31 and a 200 day moving average of $10.71. Bel Fuse Inc. has a 52-week low of $6.08 and a 52-week high of $17.60. The firm has a market capitalization of $162.64 million, a price-to-earnings ratio of 65.80 and a beta of 2.01.

Bel Fuse (NASDAQ:BELFA) last released its quarterly earnings data on Wednesday, November 4th. The scientific and technical instruments company reported $0.62 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.12 by $0.50. Bel Fuse had a return on equity of 3.50% and a net margin of 0.62%.

The company also recently announced a quarterly dividend, which will be paid on Monday, February 1st. Shareholders of record on Friday, January 15th will be issued a dividend of $0.06 per share. The ex-dividend date of this dividend is Thursday, January 14th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.82%.

Separately, Needham & Company LLC restated a “buy” rating and issued a $18.00 target price on shares of Bel Fuse in a report on Tuesday, August 11th.

Bel Fuse Profile

Bel Fuse Inc designs, manufactures, markets, and sells products that are used in the networking, telecommunication, high-speed data transmission, commercial aerospace, military, broadcasting, transportation, and consumer electronic industries in the United States, Macao, the United Kingdom, Slovakia, Germany, Switzerland, and internationally.

Read More: Support Level

Institutional Ownership by Quarter for Bel Fuse (NASDAQ:BELFA)

Receive News & Ratings for Bel Fuse Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bel Fuse and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

NanoString Technologies, Inc.  Holdings Raised by Swiss National Bank
NanoString Technologies, Inc. Holdings Raised by Swiss National Bank
Virginia Retirement Systems ET AL Sells 2,000 Shares of Dunkin’ Brands Group, Inc.
Virginia Retirement Systems ET AL Sells 2,000 Shares of Dunkin’ Brands Group, Inc.
NorthWestern Co.  Shares Sold by Virginia Retirement Systems ET AL
NorthWestern Co. Shares Sold by Virginia Retirement Systems ET AL
Federated Hermes Inc. Trims Stock Holdings in Radian Group Inc.
Federated Hermes Inc. Trims Stock Holdings in Radian Group Inc.
The Manufacturers Life Insurance Company Acquires 4,103 Shares of Adient plc
The Manufacturers Life Insurance Company Acquires 4,103 Shares of Adient plc
Skandinaviska Enskilda Banken AB publ Takes $796,000 Position in OPKO Health, Inc.
Skandinaviska Enskilda Banken AB publ Takes $796,000 Position in OPKO Health, Inc.


 
© 2006-2020 Zolmax.